Tiny Health

Tiny Health is a home gut health test for mothers and babies aged 0 to 3 years. The company sends the customer a report containing personalized evidence-based recommendations based on nutrition and diet, supplements, and lifestyle changes that parents can implement, such as not feeding baby infant probiotics, choosing a more nature-based daycare, or only using antibiotics when absolutely necessary.

Tiny Health's Baby Gut Test launched Atopic March, its first set of microbiome biomarkers for the progression of allergic diseases such as eczema, food allergies, and asthma. It also contains biomarkers for colic, insomnia, constipation, and obesity later in life.

Tiny Health headquartered in United States, North America, operates in the Biotechnology, Health Care sector. The company focuses on Biotechnology and has secured $208.0M in funding across 16 round(s). With a team of 11-50 employees, Tiny Health is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Tiny Health, raised $8.5M. Discover more about their projects, partnerships, and impact on our platform.